eupalinolide-a and Acute-Lung-Injury

eupalinolide-a has been researched along with Acute-Lung-Injury* in 1 studies

Other Studies

1 other study(ies) available for eupalinolide-a and Acute-Lung-Injury

Article	Year
Eupalinolide B attenuates lipopolysaccharide-induced acute lung injury through inhibition of NF-κB and MAPKs signaling by targeting TAK1 protein. International immunopharmacology, 2022, Volume: 111 Topics: Acute Lung Injury; Animals; Cyclooxygenase 2; Dinoprostone; Lactones; Lipopolysaccharides; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Sesquiterpenes, Germacrane	2022

Article

Year

Eupalinolide B attenuates lipopolysaccharide-induced acute lung injury through inhibition of NF-κB and MAPKs signaling by targeting TAK1 protein.

International immunopharmacology, 2022, Volume: 111

Topics: Acute Lung Injury; Animals; Cyclooxygenase 2; Dinoprostone; Lactones; Lipopolysaccharides; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Sesquiterpenes, Germacrane

2022